Cannabis is one of the most widely abused substances throughout the world. The primary
psychoactive constituent of cannabis, delta 9-tetrahydrocannabinol (▵ 9_ THC), produces a …

Despite extensive study over the past decades, available treatments for schizophrenia are
only modestly effective and cause serious metabolic and neurological side effects …

Background The aim of the current study was to investigate the association between anxiety
and cannabis use/cannabis use disorders in the general population. Methods A total of N …

Background Studies have shown a high degree of comorbidity between cannabis use
disorder (CUD) and other mental illnesses. However, there is a paucity of research on the …

Endocannabinoids and their attending cannabinoid type 1 (CB 1) receptor have been
implicated in animal models of post-traumatic stress disorder (PTSD). However, their specific …

Background Whilst cannabis use appears to be a causal risk factor for the development of
schizophrenia-related psychosis, associations with mania remain relatively unknown. This …

The antidepressant action of cannabis as well as the interaction between antidepressants
and the endocannabinoid system has been reported. This study was conducted to assess …

Cannabis sativa is best known as the source of marijuana, the world's most widely
consumed illicit recreational drug. However, the plant is also extremely useful as a source of …

The corollaries of the obesity epidemic that plagues developed societies are malnutrition
and resulting biochemical imbalances. Low levels of essential n-3 polyunsaturated fatty …

Increased peripheral levels of morning cortisol have been reported in people with
schizophrenia (SZ) and bipolar disorder (BD), but findings are inconsistent and few studies …